Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party.
Gagelmann N, Witte M, Peczynski C, Boreland W, Broers AEC, Jost E, Kulagin A, Esquirol A, Sica S, Kuball J, Errico G, Bethge W, Maertens J, Stölzel F, Forcade E, Collin M, Parma M, Choi G, Kröger N, Di Chio MC, Finazzi MC, López Corral L, Rifón J, Mussetti A, Bloor A, Ladetto M, Schoemans H, Penack O, Moiseev I, Peric Z.
Gagelmann N, et al. Among authors: boreland w.
Blood Cancer J. 2025 Jun 4;15(1):106. doi: 10.1038/s41408-025-01315-8.
Blood Cancer J. 2025.
PMID: 40467580
Free PMC article.